Copeland Capital Management LLC lifted its stake in Danaher Co. (NYSE:DHR – Get Rating) by 13.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 27,530 shares of the conglomerate’s stock after acquiring an additional 3,195 shares during the period. Copeland Capital Management LLC’s holdings in Danaher were worth $6,939,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. AE Wealth Management LLC lifted its position in Danaher by 1.6% in the fourth quarter. AE Wealth Management LLC now owns 29,903 shares of the conglomerate’s stock worth $7,937,000 after purchasing an additional 485 shares during the period. Procyon Advisors LLC lifted its position in Danaher by 42.8% in the fourth quarter. Procyon Advisors LLC now owns 2,985 shares of the conglomerate’s stock worth $792,000 after purchasing an additional 895 shares during the period. Diversified Trust Co lifted its position in Danaher by 62.2% in the first quarter. Diversified Trust Co now owns 5,093 shares of the conglomerate’s stock worth $1,284,000 after purchasing an additional 1,953 shares during the period. Van ECK Associates Corp lifted its position in Danaher by 1.4% in the fourth quarter. Van ECK Associates Corp now owns 12,045 shares of the conglomerate’s stock worth $3,197,000 after purchasing an additional 171 shares during the period. Finally, Caliber Wealth Management LLC lifted its position in Danaher by 22.7% in the first quarter. Caliber Wealth Management LLC now owns 7,664 shares of the conglomerate’s stock worth $1,932,000 after purchasing an additional 1,419 shares during the period. Institutional investors and hedge funds own 75.68% of the company’s stock.
Insider Transactions at Danaher
In other news, EVP Joakim Weidemanis sold 9,934 shares of the business’s stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $245.27, for a total transaction of $2,436,512.18. Following the completion of the transaction, the executive vice president now directly owns 91,423 shares in the company, valued at approximately $22,423,319.21. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Daniel Raskas sold 19,847 shares of Danaher stock in a transaction dated Wednesday, May 31st. The stock was sold at an average price of $228.50, for a total transaction of $4,535,039.50. Following the transaction, the senior vice president now owns 38,673 shares in the company, valued at approximately $8,836,780.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Joakim Weidemanis sold 9,934 shares of Danaher stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $245.27, for a total value of $2,436,512.18. Following the transaction, the executive vice president now owns 91,423 shares in the company, valued at approximately $22,423,319.21. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,466 shares of company stock worth $8,103,781. 11.10% of the stock is currently owned by company insiders.
Danaher Price Performance
Danaher (NYSE:DHR – Get Rating) last announced its quarterly earnings data on Tuesday, April 25th. The conglomerate reported $2.36 EPS for the quarter, topping analysts’ consensus estimates of $2.26 by $0.10. The firm had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.06 billion. Danaher had a return on equity of 16.70% and a net margin of 22.40%. The company’s revenue was down 6.8% on a year-over-year basis. During the same period last year, the company earned $2.76 earnings per share. Research analysts expect that Danaher Co. will post 9.43 EPS for the current year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a dividend of $0.27 per share. The ex-dividend date is Thursday, June 29th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s payout ratio is currently 11.64%.
Analysts Set New Price Targets
A number of brokerages have issued reports on DHR. SVB Leerink reissued an “outperform” rating on shares of Danaher in a report on Monday, May 1st. Citigroup cut their price objective on Danaher from $325.00 to $300.00 in a report on Wednesday, April 26th. Credit Suisse Group cut their price objective on Danaher from $300.00 to $270.00 in a report on Wednesday, April 26th. Stifel Nicolaus cut their price objective on Danaher from $270.00 to $250.00 in a report on Wednesday, April 26th. Finally, William Blair reissued an “outperform” rating on shares of Danaher in a report on Wednesday, April 26th. Three investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $294.06.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.
Featured Articles
- Get a free research report on Danaher from StockNews.com
- MarketBeat Week in Review – 6/19 – 6/23
- CarMax Stock Flying On Earnings Beat, Return Of The Highs?
- Commercial Metals Company Shakes Off The Rust: Confirms Uptrend
- Smith & Wesson, A Timeless Value Play At Decade Lows
- Five stocks we like better than Danaher
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
